Literature DB >> 9723692

Analysis of the TCR Vgamma repertoire in healthy donors and HIV-1-infected individuals.

D Wesch1, T Hinz, D Kabelitz.   

Abstract

During the course of infection with HIV-1, striking alterations in the subset distribution of peripheral blood gammadelta T cells are observed. While TCR Vdelta2 expression dominates among peripheral blood gammadelta T cells in healthy adults, there is a clear preponderance of Vdelta1 cells in HIV-1-infected persons. In this study, we present the first flow cytometry (FCM) analysis of the complete TCR Vgamma gene repertoire in HIV-1-infected individuals using a panel of mAb against all expressed Vgamma genes. The quantitative analysis of TCR Vgamma transcripts after amplification of cDNA by inverse PCR suggested that Vgamma5 usage is increased in HIV-1+ donors. This was confirmed by FCM with a new anti-Vgamma5 mAb. In addition, all members of the TCR VgammaI gene family (i.e. Vgamma2, 3, 4, 5 and 8) were expressed on significantly higher percentages of gammadelta T cells in HIV+ as compared to HIV- donors, whereas VgammaII (Vgamma9) expression was drastically reduced. No preferential association of the expanded Vdelta1+ cells with a particular Vgamma gene was observed in HIV-1 + donors. These results indicate that the increase in Vgamma1+ cells during HIV-1 infection occurs independently of the Vgamma gene usage and support the hypothesis that a Vdelta1-selective ligand might be involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723692     DOI: 10.1093/intimm/10.8.1067

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  21 in total

1.  Targeting γδ T cells for immunotherapy of HIV disease.

Authors:  C David Pauza; David J Riedel; Bruce L Gilliam; Robert R Redfield
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

2.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Authors:  Michael A Poles; Shady Barsoum; Wenjie Yu; Jian Yu; Patricia Sun; Jeanine Daly; Tian He; Saurabh Mehandru; Andrew Talal; Martin Markowitz; Arlene Hurley; David Ho; Linqi Zhang
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 3.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

4.  Human cytomegalovirus elicits fetal gammadelta T cell responses in utero.

Authors:  David Vermijlen; Margreet Brouwer; Catherine Donner; Corinne Liesnard; Marie Tackoen; Michel Van Rysselberge; Nicolas Twité; Michel Goldman; Arnaud Marchant; Fabienne Willems
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

Review 5.  γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.

Authors:  Cuong Thach Nguyen; Emanual Maverakis; Matthias Eberl; Iannis E Adamopoulos
Journal:  Semin Immunopathol       Date:  2019-09-10       Impact factor: 9.623

6.  Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells.

Authors:  Hendrik Ziegler; Christian Welker; Marco Sterk; Jan Haarer; Hans-Georg Rammensee; Rupert Handgretinger; Karin Schilbach
Journal:  Front Immunol       Date:  2014-12-17       Impact factor: 7.561

Review 7.  Clinical applications of gamma delta T cells with multivalent immunity.

Authors:  Drew C Deniger; Judy S Moyes; Laurence J N Cooper
Journal:  Front Immunol       Date:  2014-12-11       Impact factor: 7.561

Review 8.  Human γδT-cell subsets and their involvement in tumor immunity.

Authors:  Dang Wu; Pin Wu; Fuming Qiu; Qichun Wei; Jian Huang
Journal:  Cell Mol Immunol       Date:  2016-11-28       Impact factor: 11.530

9.  Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility.

Authors:  Sofia Berglund; Ahmed Gaballa; Piamsiri Sawaisorn; Berit Sundberg; Michael Uhlin
Journal:  Stem Cells Int       Date:  2018-03-07       Impact factor: 5.443

Review 10.  Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.

Authors:  Susann Beetz; Lothar Marischen; Dieter Kabelitz; Daniela Wesch
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.